Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist
February 12 2025 - 10:40AM
AllPennyStocks.com
Today was a big day for one small cap biotech
company. The company announced that they had acquired worldwide
exclusive license rights to a late-stage Toll-like Receptor 5
(TLR5)...
To read the full story on AllPennyStocks.com, click
here.
Statera BioPharma (NASDAQ:STAB)
Historical Stock Chart
From Feb 2025 to Mar 2025
Statera BioPharma (NASDAQ:STAB)
Historical Stock Chart
From Mar 2024 to Mar 2025
